pirinixil has been researched along with ascorbic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Columbano, A; Cossu, C; Ledda-Columbano, GM; Molotzu, F; Pibiri, M; Sanna, L; Simbula, G | 1 |
1 other study(ies) available for pirinixil and ascorbic acid
Article | Year |
---|---|
The peroxisome proliferator BR931 kills FaO cells by p53-dependent apoptosis.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Ascorbic Acid; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Cytosol; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Genes, p53; Humans; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Mitochondria; Peroxisome Proliferators; Phosphorylation; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rats; Time Factors | 2004 |